{"title":"Place des inhibiteurs de FGFR2 dans la prise en charge des cholangiocarcinomes","authors":"Blandine Delaunay, Nadim Fares","doi":"10.1684/ito.2023.407","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":499835,"journal":{"name":"Innovations & Thérapeutiques en Oncologie","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Innovations & Thérapeutiques en Oncologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1684/ito.2023.407","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}